Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Lincoln Financial (LNC)
NYSEFinancialsInsurance - LifeSnapshot 2026-11-04
$39.16-5.87%
Close 2026-11-05 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
8.75 → 8.72 EPS · FY ending Dec 31, 2027 · 8 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 8; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LNC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Sustain share buybacks | It also announced a share buyback, showing strong capital return. | Intact | No share buybacks announced or executed within next 4 quarters | Buyback executed vs target: Yes News confirms $461.8M tender offer completion (Sept 2026) and new underwriting agreement (June 2026). Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a recovery-oriented financial company, with a thesis that depends on improving earnings rather than a record of steady recent performance. The thesis is in watch status: earnings and operating income improved sharply from the first to the second quarter of 2026, but recent performance remains weak relative to its industry cohort.
LNC is described as cheap versus peers, but the expectations gap is negative and model confidence is low, so the valuation signal is uncertain. The priced-in assessment is tagged justified, with low fragility; the evidence does not point to a clearly excessive set of market expectations.
Near term, earnings could remain uneven: management’s earnings-growth priority is on track, while sales delivery is mixed, with lower Annuities sales alongside higher Life Insurance sales and modest growth in Retirement Plan Services deposits. A guidance cut or rate cuts would add pressure, while the latest reported quarter showed a sharp improvement in net income and operating income; the recent earnings beat is supportive, but the snapshot gives limited detail on how durable that improvement is.
The multi-year thesis hinges on whether improved earnings and operating income persist and whether sales across core segments strengthen. Near term, a guidance cut or lower interest rates would be unfavorable; continued earnings strength and higher guidance from sector peers could support the sector backdrop.
Over the next 1 to 3 years, LNC’s thesis rests on turning a sharp quarterly earnings improvement into a more consistent business recovery, despite weak relative performance and mixed sales. Valuation looks cheap versus peers, but confidence in that signal is low. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company keeps paying a steady dividend of $0.45 per share. |
| Intact |
| Dividend payout falls below $0.45 per share |
Dividend per share: $0.45 per share FY2026-Q2; GAAP. Published target: Dividend payout >= $0.45 per share. Target period is not explicitly aligned with this observation. Jul 30, 20260.45 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income improves toward break-even | A primary condition in Lincoln Financial's published investment case. The stated target is Operating income loss narrows to less than -$250M. | Intact | Operating income loss worsens beyond -$250M next year | Operating income: $1.643B FY2026-Q2; GAAP. Published target: Operating income loss narrows to less than -$250M. Target period is not explicitly aligned with this observation. Jul 30, 20261,643,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth at or above 5% annually | A primary condition in Lincoln Financial's published investment case. The stated target is >=5% YoY revenue growth. | Improving | YoY revenue growth falls below 4.9% next year | Revenue growth: 12.31% FY2026-Q2; GAAP. Published target: >=5% YoY revenue growth. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Jul 30, 202612.31454 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.41 → $8.72 · observed estimates
$20.48B → $20.50B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $8.41 | $20,484,852,400 | 13 / 9 |
| 2026-07-25 | $8.42 | $20,461,233,940 | 13 / 8 |
| 2026-07-26 | $8.42 | $20,461,233,940 | 13 / 8 |
| 2026-07-27 | $8.43 | $20,489,216,325 | 9 / 6 |
| 2026-07-28 | $8.42 | $20,461,233,940 | 13 / 8 |
| 2026-07-29 | $8.42 | $20,461,233,940 | 13 / 8 |
| 2026-07-30 | $8.43 | $20,489,216,325 | 9 / 6 |
| 2026-07-31 | $8.45 | $20,461,233,940 | 13 / 8 |
| 2026-08-01 | $8.49 | $20,465,994,103 | 9 / 6 |
| 2026-08-02 | $8.48 | $20,423,108,940 | 13 / 8 |
| 2026-08-03 | $8.48 | $20,423,108,940 | 13 / 8 |
| 2026-08-04 | $8.48 | $20,423,108,940 | 13 / 8 |
| 2026-08-05 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-06 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-07 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-08 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-09 | $8.52 | $20,430,446,440 | 13 / 8 |
| 2026-08-10 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-12 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-13 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-14 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-15 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-16 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-17 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-18 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-19 | $8.58 | $20,432,105,214 | 8 / 6 |
| 2026-08-20 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-21 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-22 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-23 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-24 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-25 | $8.68 | $20,435,983,435 | 8 / 5 |
| 2026-08-26 | $8.71 | $20,536,886,356 | 8 / 5 |
| 2026-08-27 | $8.71 | $20,536,886,356 | 8 / 5 |
| 2026-08-28 | $8.71 | $20,536,886,356 | 8 / 5 |
| 2026-08-29 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-08-30 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-08-31 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-01 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-02 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-03 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-04 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-05 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-06 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-07 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-08 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-09 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-10 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-11 | $8.73 | $20,566,108,578 | 8 / 5 |
| 2026-09-12 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-13 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-14 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-15 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-16 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-17 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-18 | $8.74 | $20,541,438,756 | 8 / 6 |
| 2026-09-19 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-20 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-21 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-22 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-23 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-24 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-25 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-26 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-27 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-28 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-29 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-09-30 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-01 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-02 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-03 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-04 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-05 | $8.75 | $20,541,431,700 | 8 / 6 |
| 2026-10-06 | $8.76 | $20,541,581,432 | 8 / 6 |
| 2026-10-07 | $8.78 | $20,564,477,023 | 8 / 6 |
| 2026-10-08 | $8.77 | $20,564,365,912 | 8 / 6 |
| 2026-10-09 | $8.77 | $20,564,365,912 | 8 / 6 |
| 2026-10-10 | $8.77 | $20,564,365,912 | 8 / 6 |
| 2026-10-11 | $8.77 | $20,564,365,912 | 8 / 6 |
| 2026-10-12 | $8.77 | $20,564,365,912 | 8 / 6 |
| 2026-10-13 | $8.75 | $20,522,388,411 | 8 / 6 |
| 2026-10-14 | $8.74 | $20,522,332,855 | 8 / 6 |
| 2026-10-15 | $8.74 | $20,522,332,855 | 8 / 6 |
| 2026-10-16 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-17 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-18 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-19 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-20 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-21 | $8.72 | $20,494,132,118 | 8 / 6 |
| 2026-10-22 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-23 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-24 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-25 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-26 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-27 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-28 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-29 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-30 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-10-31 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-11-01 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-11-02 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-11-03 | $8.72 | $20,500,065,651 | 8 / 6 |
| 2026-11-04 | $8.72 | $20,500,065,651 | 8 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 5 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 7 recorded
1 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.